10-Q: BellRing Brands Q3 Profit Plunges Amid Legal Costs
Quarterly Report
BellRing Brands reported a significant drop in net earnings for the third quarter and nine-month period, primarily due to substantial legal expenses, despite achieving net sales growth.
Summary
- Net sales increased by 6% to $547.5 million for the three months ended June 30, 2025, compared to $515.4 million in the prior year period.
- Net sales for the nine months ended June 30, 2025, rose by 16% to $1,668.4 million, up from $1,440.4 million in the comparable prior year period.
- Operating profit decreased by 60% to $44.8 million for the three months, down from $111.6 million, primarily due to a $68.1 million provision for legal matters.
- Net earnings for the three months ended June 30, 2025, fell by 72% to $21.0 million, compared to $73.7 million in the prior year.
- Diluted earnings per common share for the quarter was $0.16, a significant decrease from $0.56 in the prior year.
- For the nine months, operating profit decreased by 7% to $255.2 million, and net earnings decreased by 10% to $156.6 million.
- Cash provided by operating activities for the nine months decreased by $68.0 million to $91.5 million, primarily due to increased inventory levels and higher tax and interest payments.
- Long-term debt increased to $1,009.0 million as of June 30, 2025, from $833.1 million as of September 30, 2024, largely due to borrowings under the Revolving Credit Facility.
- The company repurchased 3.8 million shares of common stock for $267.6 million during the nine months ended June 30, 2025.
- Class-wide settlements in principle were reached for the Joint Juice Litigation and the Protein Products Class Lawsuit, subject to judicial approval.
Sentiment
Score: 4
Explanation: While the company achieved sales growth, the significant decline in net earnings and operating profit due to substantial legal expenses and rising input costs is a major negative. The decrease in operating cash flow and increase in debt are also concerning. Although the settlement of major litigation removes a significant overhang, the immediate financial impact was severe, leading to a cautious sentiment.
Positives
- Net sales increased by 6% for the quarter and 16% for the nine months, demonstrating continued top-line growth.
- Premier Protein product sales were up 6% for the quarter and 18% for the nine months, driven by higher volumes from distribution gains and promotional activity.
- Dymatize product sales increased by 5% for the quarter and 7% for the nine months, supported by higher international volumes and new product introductions.
- The company reached class-wide settlements in principle for both the Joint Juice Litigation and the Protein Products Class Lawsuit, potentially resolving significant legal uncertainties.
- Maintained compliance with the total net leverage ratio covenant under the Credit Agreement as of June 30, 2025.
- Operates with an asset-light business model, requiring modest capital expenditures (averaging less than 1% of net sales over the last three fiscal years).
Negatives
- Net earnings decreased significantly by 72% for the three months and 10% for the nine months, primarily due to a substantial provision for legal matters.
- Operating profit declined by 60% for the three months and 7% for the nine months, heavily impacted by legal expenses and higher product costs.
- A provision for legal matters of $68.1 million was expensed during the three months ended June 30, 2025, and $69.0 million for the nine months.
- Higher net product costs of $18.6 million for the quarter and $33.9 million for the nine months were driven by increased raw material and manufacturing costs.
- Interest expense, net, increased by $4.0 million for the quarter and $5.5 million for the nine months due to higher outstanding borrowings under the Revolving Credit Facility.
- Cash provided by operating activities decreased by $68.0 million for the nine months, primarily due to increased inventory levels ($415.6 million as of June 30, 2025, up from $286.1 million) and higher tax and interest payments.
- Increased advertising expense of $22.8 million and higher warehousing and distribution costs of $9.5 million for the nine months contributed to reduced profitability.
Risks
- Dependence on sales from ready-to-drink (RTD) protein shakes.
- Ability to continue to compete in product categories and retain market position and brand perceptions.
- Disruptions or inefficiencies in the supply chain, including reliance on third-party suppliers and manufacturers, pandemics, labor shortages, and natural disasters.
- Reliance on a limited number of third-party suppliers for certain ingredients and packaging.
- Significant volatility in the cost or availability of inputs such as freight, raw materials, packaging, energy, and labor.
- Ability to anticipate and respond to changes in consumer and customer preferences and behaviors.
- Consolidation in distribution channels.
- Loss of, or significant reduction of purchases by, a major customer.
- Legal and regulatory factors, including compliance with existing and new laws regarding food safety, advertising, labeling, tax, and environmental matters.
- Fluctuations in business due to changes in promotional activities and seasonality.
- Ability to maintain net selling prices and manage promotional activities.
- Ability to obtain additional financing and service outstanding debt, including compliance with restrictive covenants.
- Uncertain or unfavorable economic conditions that may limit customer and consumer demand or increase costs.
- Risks related to the ongoing relationship with Post Holdings, Inc. following the Spin-off, including obligations under various agreements and potential conflicting interests.
- The ultimate impact litigation or other regulatory matters may have on the company.
- Risks associated with international business.
- Ability to protect intellectual property and other assets.
- Costs, business disruptions, and reputational damage associated with technology failures, cybersecurity incidents, and data privacy breaches.
- Impairment in the carrying value of goodwill or other intangible assets.
- Ability to identify, complete, and integrate acquisitions or other strategic transactions and effectively manage growth.
- Ability to hire and retain talented personnel, and risks related to employee absenteeism, labor strikes, or unionization efforts.
- Ability to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002.
- Significant differences in actual operating results from any guidance provided.
Future Outlook
The company expects to generate positive cash flows from operations and believes its cash on hand, cash flows from operations, and possible future credit facilities will be sufficient to satisfy future working capital requirements, purchase commitments, research and development activities, debt repayments, share repurchases, and other financing needs for the foreseeable future. No significant capital expenditures are planned for the next 12 months. The company is currently evaluating the impact of the H.R.1 Tax Act, enacted on July 4, 2025, on its effective income tax rate, results of operations, financial condition, and cash flows.
Management Comments
- During fiscal 2025, input costs, including raw material, packaging, and manufacturing costs, have faced, and continue to face, inflationary pressures.
- We expect to generate positive cash flows from operations and believe our cash on hand, cash flows from operations, and possible future credit facilities will be sufficient to satisfy our future working capital requirements, purchase commitments, research and development activities, debt repayments (including interest payments), share repurchases, and other financing requirements for the foreseeable future.
- We are currently not aware of any trends or demands, commitments, events or uncertainties that will result in, or that are reasonably likely to result in, our liquidity increasing or decreasing in any material way that will impact meeting our capital needs during or beyond the next twelve months.
- Our asset-light business model requires modest capital expenditures, with annual capital expenditures over the last three fiscal years averaging less than 1% of net sales. No significant capital expenditures are planned during the next 12 months.
- We were in compliance with the financial covenant as of June 30, 2025, and we do not believe non-compliance is reasonably likely in the foreseeable future.
Industry Context
The company operates in the global convenient nutrition category, specializing in ready-to-drink (RTD) protein shakes and powders. The filing highlights ongoing inflationary pressures on input costs, including raw materials, packaging, and manufacturing, which is a common challenge across the consumer goods industry. Despite these pressures, the company's primary brands, Premier Protein and Dymatize, continue to drive sales growth through distribution gains, promotional activity, and new product introductions, indicating resilience in consumer demand for protein-based products.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to benchmark BellRing Brands' performance against industry standards.
Legal Proceedings
- **Joint Juice Litigation**: A class action lawsuit alleging false and misleading advertising for Joint Juice products. The New York Case resulted in a jury verdict against the company, with judgments for damages and attorneys' fees. Appeals were filed, and a certiorari petition was filed with the U.S. Supreme Court. A class-wide settlement in principle was reached on June 25, 2025, subject to judicial approval, with related motions to hold appeals in abeyance. The company expensed $68.1 million (Q3) and $69.0 million (9 months) related to this matter, with an estimated liability of $90.0 million as of June 30, 2025.
- **Protein Products Class Litigation**: A class action lawsuit filed in June 2023 alleging fraud and false advertising regarding high levels of undisclosed lead in RTD protein shakes and powders. A settlement for an immaterial amount was reached on June 24, 2025, and the case was voluntarily dismissed by plaintiffs on July 18, 2025.
- **California Proposition 65 Notice re Lead in Protein Products**: A 60-Day Notice of Intent to Sue issued on June 7, 2023, for alleged violation of Proposition 65 with respect to lead levels in protein products. The company intends to vigorously defend and does not believe the ultimate resolution will have a material adverse effect.
Related Party Transactions
- **Master Services Agreement (MSA) with Post Holdings, Inc. (Post)**: The company utilizes certain functions and services from Post, including finance, internal audit, treasury, IT support, insurance, tax matters, and office space. MSA fees were $0.7 million (Q3 2025) and $2.3 million (9 months 2025).
- **Intellectual Property Licensing with Post**: The company licenses certain intellectual property to and from Post and its subsidiaries, with immaterial royalties paid and received.
- **Co-Packing Agreement with Comet Processing, Inc. (Post subsidiary)**: Premier Nutrition procures packaging materials for Comet, which manufactures RTD shakes for Premier Nutrition. The company purchased $17.1 million (Q3 2025) and $44.2 million (9 months 2025) of RTD shakes from Comet.
- **Current Payables with Post**: As of June 30, 2025, the company had current payables with Post of $4.0 million, primarily related to RTD shake purchases and MSA fees.
Stakeholder Impact
- **Shareholders**: Experienced a significant negative impact on net earnings and diluted EPS, which could pressure share price. However, the company's share repurchase program aims to return value, and the settlement of major litigations reduces long-term uncertainty.
- **Customers**: Benefit from continued product availability and new product introductions. The resolution of product-related litigation may enhance consumer trust and brand perception.
- **Employees**: No direct impact on employment or compensation is detailed, but overall company performance and strategic stability can influence employee morale and retention.
- **Suppliers/Manufacturers**: The company continues to rely on third-party manufacturers and suppliers, including increased purchases from related party Comet. Ongoing inflationary pressures on input costs could affect supplier relationships and pricing.
- **Creditors**: The company's long-term debt has increased, leading to higher interest expenses. However, the company remains in compliance with its financial covenants, which is positive for creditors, indicating continued ability to meet debt obligations.
Next Steps
- Seek judicial approval for the class-wide settlement in principle related to the Joint Juice Litigation.
- Seek judicial approval for the settlement related to the Protein Products Class Lawsuit.
- Evaluate the impact of the H.R.1 Tax Act on the effective income tax rate, results of operations, financial condition, and cash flows.
- Potentially repurchase additional shares of common stock, depending on market conditions, liquidity, and contractual restrictions.
Key Dates
| Date | Description |
|---|---|
| 2013-03-01 | Complaint filed for Joint Juice Litigation against Premier Nutrition. |
| 2016-04-01 | California-only class of consumers certified in Joint Juice Litigation. |
| 2018-04-01 | Joint Juice Litigation dismissed with prejudice by district court. |
| 2020-09-01 | Joint Juice Litigation re-filed in California Superior Court for the County of Alameda. |
| 2022-03-10 | Company entered into a credit agreement for a $250.0 million Revolving Credit Facility. |
| 2022-05-01 | Trial in the New York Case (Joint Juice Litigation) began. |
| 2022-06-01 | Jury delivered verdict in favor of plaintiff in the New York Case. |
| 2022-08-01 | Court entered judgment in New York Case for $12.9 million (statutory damages and prejudgment interest). |
| 2022-10-01 | Plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit on the damages award in the New York Case. |
| 2023-06-01 | Complaint filed for Protein Products Class Lawsuit against the Company and Premier Nutrition. |
| 2023-06-07 | Fitzgerald Joseph LLP issued a 60-Day Notice of Intent to Sue under California's Proposition 65 regarding lead levels in protein products. |
| 2023-08-01 | Court entered judgment in New York Case awarding plaintiff $7.9 million in attorneys fees and costs. |
| 2023-11-01 | Joint Juice Litigation certified as a class action by the Alameda Superior Court. |
| 2023-11-01 | FASB issued ASU 2023-07, Segment Reporting, effective for fiscal years beginning after December 15, 2023. |
| 2023-12-01 | Comet Processing, Inc. (Post subsidiary) began manufacturing RTD shakes for Premier Nutrition. |
| 2023-12-01 | FASB issued ASU 2023-09, Income Taxes, effective for fiscal years beginning after December 15, 2024. |
| 2023-12-01 | Premier Nutrition filed its Notice of Appeal to the Ninth Circuit on the attorneys fees award in the New York Case. |
| 2024-08-01 | Court of Appeals issued opinion on damages award in New York Case, affirming liability, vacating/remanding damages, and reversing prejudgment interest. |
| 2024-10-01 | Premier Nutrition's petition for en banc rehearing with the Ninth Circuit Court of Appeals was denied. |
| 2024-11-19 | Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024, filed with the SEC. |
| 2025-01-01 | Plaintiff filed a motion for the application of issue preclusion arising from certain rulings in the New York Case to the California Federal Class Lawsuit. |
| 2025-01-01 | Plaintiff filed a motion for the application of issue preclusion arising from certain rulings in the New York Case to the California State Case. |
| 2025-01-25 | Ninth Circuit affirmed the trial court's attorneys fees award in the New York Case. |
| 2025-02-01 | Trial date set for February 2026 in the Related Federal Action on behalf of the class of consumers in Illinois (Illinois Case). |
| 2025-02-03 | Trial court entered an order awarding $0.9 million in attorneys fees and costs in the New York Case. |
| 2025-03-06 | Company's Board of Directors approved a new $300,000,000 share repurchase authorization, effective until March 6, 2027. |
| 2025-03-10 | Trial court entered an order again limiting statutory damages to $8.3 million under the due process clause in the New York Case. |
| 2025-03-13 | Premier Nutrition filed a certiorari petition with the United States Supreme Court seeking review of the Ninth Circuit's merits decision in the New York Case. |
| 2025-05-02 | Trial court entered an order holding that issue preclusion will apply in the Illinois Case on certain issues. |
| 2025-05-14 | Court entered an order holding that issue preclusion will apply on certain issues in the California Federal Class Lawsuit. |
| 2025-05-14 | Court entered an order holding that issue preclusion will apply on certain issues in the California State Case. |
| 2025-06-03 | Douglas Cornille (Chief Growth Officer) terminated a Rule 10b5-1 trading arrangement. |
| 2025-06-04 | Douglas Cornille (Chief Growth Officer) adopted a new Rule 10b5-1 trading arrangement. |
| 2025-06-07 | Craig L. Rosenthal (Chief Legal Officer and Chief Compliance Officer) adopted a Rule 10b5-1 trading arrangement. |
| 2025-06-24 | Parties reached a settlement related to the Protein Products Class Lawsuit for an immaterial amount. |
| 2025-06-25 | Parties reached a class-wide settlement in principle related to the Joint Juice Litigation, subject to judicial approval. |
| 2025-06-26 | Parties filed a joint motion with the United States Supreme Court to hold the certiorari petition in the New York Case in abeyance. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-02 | Parties filed a joint motion with the Ninth Circuit to hold the appeal in the New York Case in abeyance. |
| 2025-07-04 | The H.R.1 tax law was enacted in the U.S. |
| 2025-07-18 | Plaintiffs voluntarily dismissed the Protein Products Class Lawsuit. |
| 2025-07-29 | Number of common shares outstanding was 125,979,165. |
| 2025-08-05 | Date of filing of this Form 10-Q. |
| 2026-02-01 | Trial date for the Illinois Case (Joint Juice Litigation). |
| 2026-03-06 | Expiration date of the $300 million share repurchase authorization. |
| 2026-09-30 | Effective date for the Company's annual financial statements for ASU 2023-09 (Income Taxes). |
| 2027-03-10 | Repayment due date for the Revolving Credit Facility. |
| 2028-09-30 | Effective date for the Company's annual financial statements for ASU 2024-03 (Income Statement Expense Disaggregation). |
| 2030-03-01 | Maturity date for the 7.00% Senior Notes. |
Recommendation
holdWhile BellRing Brands demonstrated solid net sales growth for both the quarter and nine-month period, driven by strong performance in its Premier Protein and Dymatize brands, profitability metrics suffered significantly. Net earnings plummeted by 72% for the quarter and 10% for the nine months, primarily due to a substantial $68.1 million provision for legal matters and higher product costs. Cash flow from operations also saw a notable decrease. The company has increased its long-term debt, partly to fund share repurchases, which, while returning capital to shareholders, adds to the interest burden. The class-wide settlements in principle for the Joint Juice and Protein Products litigations are a positive development, removing a major source of uncertainty and potential future costs, but the immediate financial impact was severe. Given the mixed financial performance—sales growth offset by significant profitability declines and increased debt—a 'Hold' recommendation is appropriate. Investors should monitor the company's ability to restore profitability, manage ongoing inflationary pressures, and integrate the legal settlements without further material financial strain. The long-term outlook depends on sustained brand strength and effective cost management.
Keywords
Protein shakes, Ready-to-drink, Protein powders, Convenient nutrition, Premier Protein, Dymatize, Consumer goods, SEC filing, Quarterly report, Financial results, Legal proceedings, Supply chain, Inflation, Debt, Share repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.